| Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin … C Yoo, K Kim, JH Jeong, I Kim, MJ Kang, J Cheon, BW Kang, H Ryu, ... The Lancet Oncology 22 (11), 1560-1572, 2021 | 194 | 2021 |
| The first-week proliferative response of peripheral blood PD-1+ CD8+ T cells predicts the response to anti-PD-1 therapy in solid tumors KH Kim, J Cho, BM Ku, J Koh, JM Sun, SH Lee, JS Ahn, J Cheon, YJ Min, ... Clinical Cancer Research 25 (7), 2144-2154, 2019 | 167 | 2019 |
| Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic … YH Park, TY Kim, GM Kim, SY Kang, IH Park, JH Kim, KE Lee, HK Ahn, ... The Lancet Oncology 20 (12), 1750-1759, 2019 | 114 | 2019 |
| STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer SJ Lee, H Yang, WR Kim, YS Lee, WS Lee, SJ Kong, HJ Lee, JH Kim, ... Journal for ImmunoTherapy of Cancer 9 (6), e002195, 2021 | 68 | 2021 |
| Efficacy and Safety of Atezolizumab plus Bevacizumab in Korean Patients with Advanced Hepatocellular Carcinoma J Cheon, C Yoo, JY Hong, HS Kim, DW Lee, MA Lee, JW Kim, I Kim, ... Liver International, 2021 | 57 | 2021 |
| Real-World efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis J Cheon, HJ Chon, Y Bang, NH Park, JW Shin, KM Kim, HC Lee, J Lee, ... Liver cancer 9 (5), 613-624, 2020 | 53 | 2020 |
| Clinical Implications of Claudin18. 2 Expression in Patients With Gastric Cancer JINHO BAEK, DJIN PARK, GYUY KIM, J CHEON, BW KANG, HEEJ CHA, ... Anticancer Research 39 (12), 6973-6979, 2019 | 49 | 2019 |
| Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study HD Kim, Y Bang, MA Lee, JW Kim, JH Kim, HJ Chon, B Kang, MJ Kang, ... Liver International 40 (10), 2544-2552, 2020 | 42 | 2020 |
| Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation J Cheon, YJ Lee, JC Jo, K Kweon, SJ Koh, YJ Min, SH Park, S Lee, H Kim, ... Supportive Care in Cancer 29 (2), 975-986, 2021 | 39 | 2021 |
| Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events C Yoo, S Byeon, Y Bang, J Cheon, JW Kim, JH Kim, HJ Chon, B Kang, ... Liver International 40 (9), 2263-2271, 2020 | 36 | 2020 |
| Liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) for patients with metastatic biliary tract cancer (BTC) after progression on … C Yoo, KP Kim, I Kim, MJ Kang, J Cheon, BW Kang, H Ryu, JH Jeong, ... Journal of Clinical Oncology 39 (15_suppl), 4006-4006, 2021 | 30 | 2021 |
| The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205 S Seo, Y Moon, J Choi, S Yoon, KH Jung, J Cheon, W Kim, D Kim, ... American Journal of Cancer Research 9 (3), 597, 2019 | 29 | 2019 |
| Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective … HS Park, B Kang, HJ Chon, HS Im, CK Lee, I Kim, MJ Kang, JE Hwang, ... ESMO open 6 (2), 100049, 2021 | 27 | 2021 |
| CD45 dim CD34+ CD38− CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia SK Heo, EK Noh, LJ Ju, JY Sung, YK Jeong, J Cheon, SJ Koh, YJ Min, ... BMC cancer 20 (1), 1-10, 2020 | 26 | 2020 |
| High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer HS Park, YM Kim, S Kim, WS Lee, SJ Kong, H Yang, B Kang, J Cheon, ... Journal for immunotherapy of cancer 9 (10), 2021 | 25 | 2021 |
| Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer HJ An, HJ Jeon, SH Chun, HA Jung, HK Ahn, KH Lee, M Kim, JH Kim, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2019 | 21 | 2019 |
| Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis J Cheon, C Lee, YB Sang, HJ Choi, MH Kim, JH Ji, KH Ko, CI Kwon, ... Therapeutic Advances in Medical Oncology 13, 17588359211035983, 2021 | 19 | 2021 |
| Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea J Cheon, C Kim, EJ Park, M Ock, H Lee, JJ Ahn, Y Jegal, KW Seo, ... Journal of Thoracic Disease 12 (9), 4950, 2020 | 19 | 2020 |
| Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter … H Chae, H Jeong, J Cheon, HJ Chon, H Ryu, IH Kim, MJ Kang, JH Jeong, ... Therapeutic Advances in Medical Oncology 12, 1758835920923424, 2020 | 19 | 2020 |
| Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cells SK Heo, EK Noh, JY Kim, SH Jegal, Y Jeong, J Cheon, SJ Koh, JH Baek, ... Phytomedicine 49, 66-74, 2018 | 18 | 2018 |
